Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Lidocaine Infusion for Chronic Cancer-related Pain
NCT01384877Phase 3Completed
- Sponsor
- BC Cancer
- Start
- Dec 2011
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Lidocaine Hydrochloride Injection, without epinephrine in cancer pain, sponsored by BC Cancer. Started Dec 2011; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT01384877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01384877.